GenoLogics Eyes Next-Gen LIMS Market

Bio-IT World (Mar 29 2011) Pharmaceuticals

1. A recent partnership with Illumina is taking the company to ‘another level.’ By Kevin Davies March 29, 2011 | Michael Ball, CEO of GenoLogics, thinks that Illumina’s recent partnership with his company to sell GenoLogics’ LIMS (Laboratory Information Management System) (Read Full Article)

   Bookmark or Share this article

Login to comment.